Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
“My loss is minimal” LMBO. The “claims” of buying multiple blocks of 25k shares at much higher prices. Or post dump last October of several $10k blocks while we were in the $1.60’s. You were close to achieving the 200,000 goal a long time ago weren’t you. Now “invested” around a year and a half, down “minimally” (LMBOx200,000-196,000) and you don’t grasp the concept of DEAD MONEY. And no clue as to what a bucket shop is? How’s Advaxis working out for you. Jumped into that one in the $6’s and now under a buck, and still promoting it eh... BRILLIANT. Thanks for the laughs. Head pop out in China yet since you’re heads buried so deep. Pluristam has been sinking for almost a year now. Where will it end.
Real Longs? Just because I can’t stand how this company is run, or worse how people try to justify these idiots, doesn’t make me a fake long. Sure I don’t sit there and pretend I have 300,000 shares like some do, but I am long nonetheless.
And yes that spike is nice. But how many little spikes have we seen that just go down again come Monday?
Don’t think I saw this before from the latest quarter. “...for both parties to a contract”. Ohhhhh. Ahhhhh. Off to the moon. Giddy up. All aboard. Next conference would be a great place to announce some news. Management rules!!! Double the free shares on that zinger. Diluting the company with 10% free shares brings great value to any long!!! Why use them to support business plan when they’re better off directly in their hands. All the cool Biotech’s are doing it.
That’s all you do thesaurus boy. No need to tell us. Like I said many tines, gives no credence to your feeble attempts to make it look like you have a clue at all. Keep trying and wait for the 4 am praise. Ohhhhh. Ahhhhhh. LMBOx200,000-194,000.
I Do If Others Try
Yes thesaurus boy I truly could care less. None of you post anything of relevance. Just belieb and be happy not having lost “too much”. There’s no logical response to my questions and statement I have made for many months. Because there are none. Too bad the thesaurus can’t to that huh.
I Do If Others Try. Sure you can figure that one out right? Just check the thesaurus. And yes here’s the token LMBOx200,000-194,000. You know why.
Care to provide links to your “facts”. That’s what you have been saying for years. Maybe that’s where I’m remembering it from. So ya, it must be true.
Doctors are pretty accurate on predicting time of death. Stephen Hawkins being the perfect example of that. Now throw in a CEO stating that right before he sold at the top, makes it even more reliable. Released data on about 30 patients pretty much confirms we have hit a homer run. And our soaring price confirms it.
We’ll get em next week!!!
10q out 10q out!!! Sosei is still on the table. Whew!!! This may be enough to put us right back into the $1.35’s. Go Pluristem!!!
I am soooooooo excited. That Lonza partnership should happen any time. Ohhhhhh. Ahhhhhhh. Now that we have traded in the $1.40’s for almost half hour now, it’s official. We are NOW solidly in the $1.40’s. High fives are flying. Greatest day for Pluristem in I don’t know how long. Could just be market driven though. Computer algo’s kicking in to high gear. Someone leak some highly classified governmental news? Navy seals testing it out possibly? Sosei close? Vial explode in Kaki’s pocket and we found the new purple pill that lasts for weeks? Ladies are lovin Kaki right now. Or...drumroll please...They made a milestone. A surprise milestone if we are lucky. Cmon next week. We will get em!!! Ohhhhhh ahhhhhh. Crowds going CRAZY!!! Anything just under $2, was a steal!!!! Ohhhhhh. Ahhhhhhh
Or maybe the pre AGM pump!!! Ohhhhhhh. Ahhhhhhhhh.
I’m downright giddy on our price. Ahhhhhhh. We are up a penny today right now. I can hardly contain myself. Soon we will have traded 30,000 shares...and we are only an hour in!!! The hills are alive...excuse me while I vomit.
My bad, we have been up a penny today at times. High fives all around. If we could do the same tomorrow, I’ll count that as being solidly in the $1.40’s. But it could just be market related. Or the top secret government classification now. Hopefully Kaki and company can get security clearance. Not supposed to be any price appreciation until then.
Not only are they sitting on one, employees have been reaping rewards from it for years!!! Go Pluristem!!! We’ll get em next week!!!
Yes they’re skipping the interim results and heading for results this month. Can’t wait!!! I don’t know why I didn’t believe them when they declared 2017 as the year of the shareholder. Silly me!!!
Even with the addition you speak of, they are still over 4 months late on interim results. But Zami gave the big update in one interview recently, um ah, no safety issues so far. At least the study shows completion date of May 2018. Only 28 days to go so them making that “milestone” is probably a given. Can’t wait!!! Way to go management. Keep the people YOU work for, the shareholders, in the dark. That’s what good management does. Transparency is overrated after all. Stock market hates it actually. All eyes must be fully focused on the upcoming lottery. Cristal on order, after party booked, no expenses spared. You made it to the big leagues Zami and Kaki... congrats!!! You’re not the reason our share price sucks whatsoever!!! I’m “ok” with them.
The person who quotes “dead money” like you say, has been spot on with the pricing. Would have saved many a significant percentage on purchases if their advice were taken. Also, the term dead money fits perfectly with this company. If you have money sitting in this stock for years with zero appreciation and a only declining share price, I don’t know what else you could call it. And I’m not even talking about the time value of money. That just supports the claim further.
Someone who knew this management sucked!!! BIG TIME!!! When’s the new and improved guess on the Lonza partnership? Changes more than Pluristems milestones, which is quite the accomplishment. Cmon 4 am eh!!!
I heard Lonza wants a piece of Japan. Any day now right. Jokes but applause should happen come 4 am.
Yes hopefully we do get to laugh one day. Years and years of false promises. Yes that day may come when they come out and brag how they told us so. We have been here a very long time and yes we did assist in them getting to a point that they are now. Not much on my part, as I’m not throwing in half a million like some claim to. But a part nonetheless. No doubt in my mind we would have been laughing already had experienced people running this. They were the pioneers right?
You think partnering is the only reason some are pissed at this management? First of all, THEY are the ones touting the increased interest from companies wanting to. They are the ones that have said they want to partner for at least the last 5 years right? What about Sosei. Can’t even close that. Pathetic.
But what about the lack of explanation for pretty much anything, not just partnerships. Where’s the explanation of the more than 2 1/2 expected timeframe on preclinical work? Where’s the explanation for pretty much any and all of their missed milestones? Cowards is what they are. That fiscal year end shareholder update was absolutely pathetic. We should all praise them for that one right? Why not take the time to explain these constant misses, instead of pretending they didnt happen. Or how their PR’s now contain jumbled wording to keep everyone guessing as to what it actually means. They communicate nothing to us!!!
You keep saying their pay is the norm for this size of a company. Please show me another where they gifted themselves $2.5 million shares. Not just for one clown but for 2. Both pulling in half a million dollar salary, getting percentages of any non diluting funding. Or how about showing me a similar stage company that has had the same number of employees for all these years. And how about the upcoming lottery where the Cristal will be flowing.
They have been acting like they have made it huge, long before they have made it, as it still hasn’t happened...for shareholders anyways. So these are pretty valid reasons for real shareholders to be upset. How one wouldn’t, still baffles me. THESE are the reasons news like yesterday does pretty much nothing for the price. I’m sorry but another company without the dead wood running it would have seen a substantial, sustained run for more than just a day or two. Little to no interest not because it’s stiln a secret, but because this management team has failed to communicate with shareholders, and continues to pad their own pockets. Many have been here for more than 5 years, and they have shafted them the whole way. What about these people eh, who have enabled this company to accomplish what they have done to date.
But I do believe we will see that run coming soon. Just hopefully we don’t get another raise stuffed in our face to send hopes crashing back down like we did in October.
I see what you’re saying. That sentence could be there just to keep the near term hopes alive. Who knows. It could seem to suggest they stock it themselves, just why would they waste their money in doing so. Doesn’t make sense. I could see them getting prepared for an order that is forthcoming. Not a large one, but $50 mil or under. At least until/if they get full approval, in 2019. That authorized use may have been what the government was waiting for, and makes the process that much easier.
I understand the skepticism more than most. We will have to wait and see what happens.
It is pretty sad when we get news like this and we hit the low $1.30’s. Don’t disagree with you much on anything when it comes to this stock, but I think this is one of the bigger news we have seen to date. They have actually gotten a product to a stage where it could be sold. And it puts us to a spot where we could see a stockpiling contract, contrary to the news that was just released. Clarity is not something this company is good at whatsoever. And Zami did say no stockpiling for any country other than US until fda approval.
The news release does say preparations to stock, not that I believe or know what they say for good reason. But either way, the street really doesn’t care about this release, at least in terms of price. Would be nice to see them follow with a contract, partner, something. Hate seeing this thing drift back down time and time again. Like I said before, we are getting ever closer to the AGM, so I am expecting the price to go up befor then. We will see.
Go take a look at January 2017’s presentation. Clearly states there that initiation of pivotal trial will start in 2H17. Presentations, the only means this horrific management communicates to shareholders, should be taken seriously. They make most milestones after all right. Kaki’s statement is the clearest one in that release. No twisting that one. Wow!!!
Of course you would try to discredit what KAKI states himself. Why believe what they tell us is the truth. They haven’t yet. So maybe you could be right. What they tell us is always the opposite so we should actually get ARS approved this year. Whew. And here I thought Kaki was telling the truth. Silly me.
Just like the lie clinical trials website shows about 30 injections. They probably just took liberties and added that 30 injections because it sounded better. They’re good that way, filling in the blanks when Kaki’s company forgot to fill in. Thanks CT.
We will just have to wait for the other half to support your claim, and now my claim as well. . Anxiously await to see the support of our statements made.
I’d call Kaki something a little more fitting, but I would be banned. So Kaki is the most fitting term for the wonderful job he does on behalf of us all. Heck give him the whole 5 million share bonus.
Unfortunately this becomes more and more evident as the quarters and years fly by. Can’t wait for the lottery, when everyone here will be happy with another 5% dilution event. As long as there’s no bad news with our trials, I’m “ok” with everything else. The leaders will be truly deserving of their 1 to 2 million bonuses. Of course it’s possible they might opt not to partake this year. And those NHP’s might fly out of my butt.
I’m not sure what the site you referenced, CenterWatch actually does as when you click on about for this site, it brings you to a webinar only. That’s why I was surprised and skeptical when I saw such a high success rate that you stated. This is taken from FDA site on phase 3 trials.
“Study Participants: 300 to 3,000 volunteers who have the disease or condition
Length of Study: 1 to 4 years
Purpose: Efficacy and monitoring of adverse reactions
Approximately 25-30% of drugs move to the next phase”
https://www.fda.gov/ForPatients/Approvals/Drugs/ucm405622.htm
And you don’t even mention that we are jumping from phase 1 results, right to phase 3. Phase 1/2’s is a different beast altogether. Neither of our phase 3’s had a true phase 2, with a significant patient size. So the odds of success would be significantly less don’t you think?
Now biologics is a newer field, so the success rate would most likely be different. Just like cancer treatments have a higher failure rate. Could be higher or lower, I don’t know. But that 70 to 90 percent chance, is substantially higher than what I think it is. But in a few years time, we will all know. As long as they can fund it that long.
So I guess you’re still positive about managements ability to run this company. They are “ok” after all. Inexperience has absolutely nothing to do with their ever growing misses on a vast majority of their milestones? You can very easily look at the January 2017 presentation, where their milestone was to start pivotal trial in 2017. All to allow them to pump up the price? And sucker in new investors. Kept touting it all the way until the “next 12 months” as their new milestone motto. We are potentially looking at a 2 year miss on this one. The one that the government so desperately wanted. Legislation was changed just for us right. What’s the excuse this time around? Governmental red tape? These designs often take 3 years? Monkeys have formed a union?
Kaki himself states the following right in the releas.
“We expect to collect data from these studies to support the initiation of the pivotal study protocol, an essential step in the PLX-R18 product development.”
So until this data is collected, pivotal trial won’t be initiated. So to think that within a year we will have the pivotal trial completed is pretty fictitious. Or should the pivotal trial fly by with ease now? No more complicated designs, animal rights, stuff of that nature you used to show the reasons for delays earlier.
Now you try and state right in line with expectations??? Seriously. THEY stated 2017. Really don’t know what you were expecting, but I sure wasn’t expecting this. Hopefully the newly duped Israeli investors don’t either, and give them the boot they all deserve.
Not as much as people here who are happy with the price near 52 week lows. As long as people aren’t down “too much” right. All with absolutely zero concern how this company is run. Really what in this PR did you think was so “nice”. With it already being on CT site, did you think it wasn’t already given the green light? I already thought that as I’m sure most others did. But on a bright note we may get some data from it in the new improved year of the shareholder, 2020.
Realists on this board are a rarity.
Yes amazing news!!! And here I thought they already had clearance since the trial was already listed on clinical trials. Boy I have to up my DD. How this hasn’t put us solidly into the $1.30’s is astonishing. I guess it’s early in the day so you never know. Highly unlikely we will drift back down on this unbelievable news. Go Pluristem!!!
Not if someone else makes it there first. At the rate they move, it’s a real possibility unfortunately.
One thing that is always consistent with their releases, is wording things to purposely confuse the issue. If that pivotal study doesn’t start for a year, that will definitely suck. That would mean late 19 to early 20 for approval. Only 2 years behind on that one if that’s the case. Any day now we should get a stockpiling contract from the new legislation that was put in place for us right.
At least by that time we will hopefully have 40 CLI sites up and running. Or get interim HCT, and preclinical NYBC and Fukushima. Oh it’s going to be exciting in a couple of years. And they said 2017 was going to be our year. 2020 is the new and improved “our year”. That’s what great management does!!! Eat our dust!!! Just wait until we’re known in this industry. We’re going to take off!!!
Cmon now EichKing, you wouldn’t expect nothing less than the misinterpretation of what was said and factual. The twins never make something up now do they? Boy if THEY’RE saying a year, how long is it really going to take. What happened to 2017?
And weren’t they supposed to be the pioneers in this industry? How did others manage to overtake us? Never look at the facts, just twist them to suit your need. If you did get in at the prices now, rather than the $2’s, it WILL make a big difference at any price that’s higher. But everyone is perpetually happy with where we’re at. Go figure.
I put zero into it. The likelihood of this person posting is slim. For their sake, I hope they ha e. Too many posters coming out of the woodwork. For their sake I hope they’re in the trial. That one crosses the line if they’re making it up.
No You are wrong. It IS 30 injections. Go look at clinical trials site below and look under the arms chart. Clearly shows it.
“PLX-PAD will be administered via 30 IM injections (0.5 mL each). Each subject will be treated twice, with an interval of 8 weeks between treatments.“
https://clinicaltrials.gov/ct2/show/NCT03006770?term=Pluristem&rank=2
P.S. God bless the families involved in Toronto from that cowardly attack. Absolutely horrific.
And your call of dead money has been a much more accurate term than the many calls that under $2 is a steal. Or under $1.60 is a steal. Solid base in the $1.30’s. Uh $1.20’s. We made it back to the $1.20’s hooray!!! Or the great “I’m not down too much”. LMBOx200,000-193,990.
New Tutes!!!
2018-04-19 Asset Dedication LLC... 500 shares
2018-04-05 West Oak Capital LLC... 400 shares
Interest in this company is starting!!! Low volume IS good. T-900, 899, 898...
At least you admitted they ARE facts. When/if they change is the question. Good start.
Wow someone that lives in reality. What a breath of fresh air. That was me when they first started, well over a decade ago. It was unknown then. That’s when I used to be a belieber too. But that excuse went out the door long ago. Except here of course. Here it’s like the biotech industry has still just begun. It hasn’t. So many biological that are getting closer to approval. With all the pathways available now, it will only speed that up. We just like to talk about the fast tracks we have for years now. Nothing is fast with these bozos. Except acceptance to any new show that comes. On top of that. Or bonuses. Pretty much a give no matter what happens.
It either has to be our product, or our management that keeps us where we are. I think our product is top notch. Or at least the source of our product is. Makes sense being such young cells that are harvested, rather than an older patients old cells. So that leaves the latter. Ignore me all you like, doesn’t make the gazziliion posts I’ve shown of their incompetence false. You know I’m right. But maybe the new hire will change that. They got 3rd place ranking on the about page. Big gun from the $34 million market cap company, Immuron. What a find don’t you think.
And The chosen one posted a few days back about Lonza’s giant facility they built. We should have been the ones announcing that, but the gong
Welcome. Where declining prices are a good thing and Lonza partnership is around the corner. Free shares for the top, and a finger for the longs. Not the thumb, that’s for sure. Missed milestones are made ones. Perpetual 12 month milestones that never change in our presentation ensures we will no longer miss another milestone again. That’s management thinking outside the box. Declining price on higher volume are good signs. Sitting near 52 week lows is a great buying opportunity, as it has been ever since the steady decline from highs during the pump last year. Heck if you’re lucky, you too can be down “not too much” and still be in good shape. That’s only if you’re lucky enough to be down though. But with patience, you can succeed too.
Never once have I stated I’m any sort of professional investor. But I do like a gamble. And that is all this stock has been from day one. But with these gong show rejects running it, the lottery may be a better play.
Yes tons of possibilities. But with some of them being more than 2 and a half time the original estimate, and EVERY single one of them late, does not bode well. And here I thought we MADE most of our milestones. Don’t know where I heard that from. Must have been a professional CEO that said something along those lines. Wuff wuff.
You should look around at competitors like I have. Then you will see that the world already has. Unfortunately Pluristem hasn’t participated in any of the gains this sector has seen in the last 10 years. Any day now. Do yourself a favor and take a good look at management. It’s pretty telling on why our price is where it is. And good luck with your high risk gamble.
Like EichKing and I have said a million times in response to you’re repeated question, been in it too long. Not going to chance that the 2 idiots get lucky or have some big pharma take them out for half a billion or so. Or if we get amazing results in IC. 1H18. Or if we ever get interim results from HCT 2H 17. Or if we ever get preclinical data from Fukushima or NYBC, 1H17. Or if we ever close Sosei. Or when we get Japanes fast track started. Or when we get 40 clinics up and running in 2017. Or when ARS contract comes later in 2017. Or when the Pluristem lottery happens come the AGM. Anxious to see how many shares dumb and dumber get for their hard work. And especially can’t wait for the Lonza partnership to come to fruition. They did open shop in Haifa remember.
Capish? Wuff wuff